Selected research
Market Structure
Global Medical Radioisotopes Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Medical Radioisotopes market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The US & Canada market for Medical Radioisotopes is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Medical Radioisotopes is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Medical Radioisotopes is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Medical Radioisotopes is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Medical Radioisotopes include NRG, IRE, ANSTO, NTP Radioisotopes, China National Nuclear Corporation, Rosatom, Nordion, Eckert & Ziegler Strahlen and Polatom, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Includes
This report provides an overview of the global Medical Radioisotopes market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Medical Radioisotopes and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Medical Radioisotopes revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Medical Radioisotopes market size, projected growth trends, production technologies, key applications, and end-use industries.
Medical Radioisotopes Segment by Company
NRG
IRE
ANSTO
NTP Radioisotopes
China National Nuclear Corporation
Rosatom
Nordion
Eckert & Ziegler Strahlen
Polatom
Medical Radioisotopes Segment by Type
Tc-99m
Cobalt-60
Iodine Radioisotopes
Medical Radioisotopes Segment by Application
Nuclear Therapy
Equipment Radioactive Source
Diagnosis
Others
Medical Radioisotopes Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Medical Radioisotopes market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Medical Radioisotopes and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Medical Radioisotopes.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Medical Radioisotopes in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Medical Radioisotopes industry.
Chapter 3: Detailed analysis of Medical Radioisotopes companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Medical Radioisotopesrevenue, gross margin, and recent development, etc.
Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 8: Europe by type, by application and by country, revenue for each segment.
Chapter 9: China by type, and by application, revenue for each segment.
Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.
Chapter 12: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Tc-99m
- Cobalt-60
- Iodine Radioisotopes
Applications
- Nuclear Therapy
- Equipment Radioactive Source
- Diagnosis
- Others
Companies covered
- NRG
- IRE
- ANSTO
- NTP Radioisotopes
- China National Nuclear Corporation
- Rosatom
- Nordion
- Eckert & Ziegler Strahlen
- Polatom
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Market Analysis by Type
- 1.2.1 Global Medical Radioisotopes Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
- 1.2.2 Tc-99m
- 1.2.3 Cobalt-60
- 1.2.4 Iodine Radioisotopes
- 1.3 Market Analysis by Application
- 1.3.1 Global Medical Radioisotopes Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
- 1.3.2 Nuclear Therapy
- 1.3.3 Equipment Radioactive Source
- 1.3.4 Diagnosis
- 1.3.5 Others
- 1.4 Global Market Growth Prospects
- 1.5 Global Medical Radioisotopes Growth Trends by Region
- 1.5.1 Global Medical Radioisotopes Market Size by Region: 2021 VS 2025 VS 2032
- 1.5.2 Medical Radioisotopes Market Size by Region (2021-2026)
- 1.5.3 Medical Radioisotopes Market Size by Region (2027-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
- 1.8 Years Considered
2 Global Medical Radioisotopes Market Dynamics
- 2.1 Medical Radioisotopes Industry Trends
- 2.2 Medical Radioisotopes Industry Drivers
- 2.3 Medical Radioisotopes Industry Opportunities and Challenges
- 2.4 Medical Radioisotopes Industry Restraints
3 Competitive Landscape by Company
- 3.1 Global Medical Radioisotopes Revenue by Company (2021-2026)
- 3.2 Global Medical Radioisotopes Players Revenue Ranking, 2024 VS 2025 VS 2026
- 3.3 Global Medical Radioisotopes Key Company Head office and Area Served
- 3.4 Global Medical Radioisotopes Company, Product Type & Application
- 3.5 Global Medical Radioisotopes Company Establishment Date
- 3.6 Market Competitive Analysis
- 3.6.1 Global Medical Radioisotopes Market CR5 and HHI
- 3.6.2 Global Top 5 and 10 Medical Radioisotopes Players Market Share by Revenue in 2025
- 3.6.3 2025 Medical Radioisotopes Tier 1, Tier 2, and Tier 3
4 Medical Radioisotopes Market by Type
- 4.1 Global Medical Radioisotopes Market Size by Type (2021 VS 2025 VS 2032)
- 4.2 Global Medical Radioisotopes Market Size by Type (2021-2032)
- 4.3 Global Medical Radioisotopes Market Size Share by Type (2021-2032)
5 Medical Radioisotopes Market by Application
- 5.1 Global Medical Radioisotopes Market Size by Application (2021 VS 2025 VS 2032)
- 5.2 Global Medical Radioisotopes Market Size by Application (2021-2032)
- 5.3 Global Medical Radioisotopes Market Size Share by Application (2021-2032)
6 Company Profiles
- 6.1 NRG
- 6.1.1 NRG Company Information
- 6.1.2 NRG Business Overview
- 6.1.3 NRG Medical Radioisotopes Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.1.4 NRG Medical Radioisotopes Product Portfolio
- 6.1.5 NRG Recent Developments
- 6.2 IRE
- 6.2.1 IRE Company Information
- 6.2.2 IRE Business Overview
- 6.2.3 IRE Medical Radioisotopes Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.2.4 IRE Medical Radioisotopes Product Portfolio
- 6.2.5 IRE Recent Developments
- 6.3 ANSTO
- 6.3.1 ANSTO Company Information
- 6.3.2 ANSTO Business Overview
- 6.3.3 ANSTO Medical Radioisotopes Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.3.4 ANSTO Medical Radioisotopes Product Portfolio
- 6.3.5 ANSTO Recent Developments
- 6.4 NTP Radioisotopes
- 6.4.1 NTP Radioisotopes Company Information
- 6.4.2 NTP Radioisotopes Business Overview
- 6.4.3 NTP Radioisotopes Medical Radioisotopes Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.4.4 NTP Radioisotopes Medical Radioisotopes Product Portfolio
- 6.4.5 NTP Radioisotopes Recent Developments
- 6.5 China National Nuclear Corporation
- 6.5.1 China National Nuclear Corporation Company Information
- 6.5.2 China National Nuclear Corporation Business Overview
- 6.5.3 China National Nuclear Corporation Medical Radioisotopes Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.5.4 China National Nuclear Corporation Medical Radioisotopes Product Portfolio
- 6.5.5 China National Nuclear Corporation Recent Developments
- 6.6 Rosatom
- 6.6.1 Rosatom Company Information
- 6.6.2 Rosatom Business Overview
- 6.6.3 Rosatom Medical Radioisotopes Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.6.4 Rosatom Medical Radioisotopes Product Portfolio
- 6.6.5 Rosatom Recent Developments
- 6.7 Nordion
- 6.7.1 Nordion Company Information
- 6.7.2 Nordion Business Overview
- 6.7.3 Nordion Medical Radioisotopes Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.7.4 Nordion Medical Radioisotopes Product Portfolio
- 6.7.5 Nordion Recent Developments
- 6.8 Eckert & Ziegler Strahlen
- 6.8.1 Eckert & Ziegler Strahlen Company Information
- 6.8.2 Eckert & Ziegler Strahlen Business Overview
- 6.8.3 Eckert & Ziegler Strahlen Medical Radioisotopes Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.8.4 Eckert & Ziegler Strahlen Medical Radioisotopes Product Portfolio
- 6.8.5 Eckert & Ziegler Strahlen Recent Developments
- 6.9 Polatom
- 6.9.1 Polatom Company Information
- 6.9.2 Polatom Business Overview
- 6.9.3 Polatom Medical Radioisotopes Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.9.4 Polatom Medical Radioisotopes Product Portfolio
- 6.9.5 Polatom Recent Developments
7 North America
- 7.1 North America Medical Radioisotopes Market Size (2021-2032)
- 7.2 North America Medical Radioisotopes Market Size by Type
- 7.2.1 North America Medical Radioisotopes Market Size by Type (2021-2026)
- 7.2.2 North America Medical Radioisotopes Market Size by Type (2027-2032)
- 7.2.3 North America Medical Radioisotopes Market Share by Type (2021-2032)
- 7.3 North America Medical Radioisotopes Market Size by Application
- 7.3.1 North America Medical Radioisotopes Market Size by Application (2021-2026)
- 7.3.2 North America Medical Radioisotopes Market Size by Application (2027-2032)
- 7.3.3 North America Medical Radioisotopes Market Share by Application (2021-2032)
- 7.4 North America Medical Radioisotopes Market Size by Country
- 7.4.1 North America Medical Radioisotopes Market Size by Country (2021 VS 2025 VS 2032)
- 7.4.2 North America Medical Radioisotopes Market Size by Country (2021-2026)
- 7.4.3 North America Medical Radioisotopes Market Size by Country (2027-2032)
- 7.4.4 North America Medical Radioisotopes Market Share by Country (2021-2032)
- 7.4.5 United States
- 7.4.6 Canada
- 7.4.7 Mexico
8 Europe
- 8.1 Europe Medical Radioisotopes Market Size (2021-2032)
- 8.2 Europe Medical Radioisotopes Market Size by Type
- 8.2.1 Europe Medical Radioisotopes Market Size by Type (2021-2026)
- 8.2.2 Europe Medical Radioisotopes Market Size by Type (2027-2032)
- 8.2.3 Europe Medical Radioisotopes Market Share by Type (2021-2032)
- 8.3 Europe Medical Radioisotopes Market Size by Application
- 8.3.1 Europe Medical Radioisotopes Market Size by Application (2021-2026)
- 8.3.2 Europe Medical Radioisotopes Market Size by Application (2027-2032)
- 8.3.3 Europe Medical Radioisotopes Market Share by Application (2021-2032)
- 8.4 Europe Medical Radioisotopes Market Size by Country
- 8.4.1 Europe Medical Radioisotopes Market Size by Country (2021 VS 2025 VS 2032)
- 8.4.2 Europe Medical Radioisotopes Market Size by Country (2021-2026)
- 8.4.3 Europe Medical Radioisotopes Market Size by Country (2027-2032)
- 8.4.4 Europe Medical Radioisotopes Market Share by Country (2021-2032)
- 8.4.5 Germany
- 8.4.6 France
- 8.4.7 U.K.
- 8.4.8 Italy
- 8.4.9 Russia
- 8.4.10 Nordic Countries
9 China
- 9.1 China Medical Radioisotopes Market Size (2021-2032)
- 9.2 China Medical Radioisotopes Market Size by Type
- 9.2.1 China Medical Radioisotopes Market Size by Type (2021-2026)
- 9.2.2 China Medical Radioisotopes Market Size by Type (2027-2032)
- 9.2.3 China Medical Radioisotopes Market Share by Type (2021-2032)
- 9.3 China Medical Radioisotopes Market Size by Application
- 9.3.1 China Medical Radioisotopes Market Size by Application (2021-2026)
- 9.3.2 China Medical Radioisotopes Market Size by Application (2027-2032)
- 9.3.3 China Medical Radioisotopes Market Share by Application (2021-2032)
10 Asia (Excluding China)
- 10.1 Asia Medical Radioisotopes Market Size (2021-2032)
- 10.2 Asia Medical Radioisotopes Market Size by Type
- 10.2.1 Asia Medical Radioisotopes Market Size by Type (2021-2026)
- 10.2.2 Asia Medical Radioisotopes Market Size by Type (2027-2032)
- 10.2.3 Asia Medical Radioisotopes Market Share by Type (2021-2032)
- 10.3 Asia Medical Radioisotopes Market Size by Application
- 10.3.1 Asia Medical Radioisotopes Market Size by Application (2021-2026)
- 10.3.2 Asia Medical Radioisotopes Market Size by Application (2027-2032)
- 10.3.3 Asia Medical Radioisotopes Market Share by Application (2021-2032)
- 10.4 Asia Medical Radioisotopes Market Size by Country
- 10.4.1 Asia Medical Radioisotopes Market Size by Country (2021 VS 2025 VS 2032)
- 10.4.2 Asia Medical Radioisotopes Market Size by Country (2021-2026)
- 10.4.3 Asia Medical Radioisotopes Market Size by Country (2027-2032)
- 10.4.4 Asia Medical Radioisotopes Market Share by Country (2021-2032)
- 10.4.5 Japan
- 10.4.6 South Korea
- 10.4.7 Taiwan
- 10.4.8 Southeast Asia
- 10.4.9 India
- 10.4.10 Australia
11 South America, Middle East & Africa
- 11.1 South America, Middle East & Africa Medical Radioisotopes Market Size (2021-2032)
- 11.2 South America, Middle East & Africa Medical Radioisotopes Market Size by Type
- 11.2.1 South America, Middle East & Africa Medical Radioisotopes Market Size by Type (2021-2026)
- 11.2.2 South America, Middle East & Africa Medical Radioisotopes Market Size by Type (2027-2032)
- 11.2.3 South America, Middle East & Africa Medical Radioisotopes Market Share by Type (2021-2032)
- 11.3 South America, Middle East & Africa Medical Radioisotopes Market Size by Application
- 11.3.1 South America, Middle East & Africa Medical Radioisotopes Market Size by Application (2021-2026)
- 11.3.2 South America, Middle East & Africa Medical Radioisotopes Market Size by Application (2027-2032)
- 11.3.3 South America, Middle East & Africa Medical Radioisotopes Market Share by Application (2021-2032)
- 11.4 South America, Middle East & Africa Medical Radioisotopes Market Size by Country
- 11.4.1 South America, Middle East & Africa Medical Radioisotopes Market Size by Country (2021 VS 2025 VS 2032)
- 11.4.2 South America, Middle East & Africa Medical Radioisotopes Market Size by Country (2021-2026)
- 11.4.3 South America, Middle East & Africa Medical Radioisotopes Market Size by Country (2027-2032)
- 11.4.4 South America, Middle East & Africa Medical Radioisotopes Market Share by Country (2021-2032)
- 11.4.5 Brazil
- 11.4.6 South Africa
- 11.4.7 Saudi Arabia
- 11.4.8 Turkey
- 11.4.9 Argentina
- 11.4.9 UAE
- 11.4.9 Egypt
- 11.4.9 Chile
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
- 13.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst